Procter & Gamble Health Live BSE/NSE | Procter & Gamble Health Fundamenta data | Procter & Gamble Health Balance sheet | Procter & Gamble Health Quarterly Results | Procter & Gamble Health Profit & Loss

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

7,307.21
44.42
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

6,063.79
10.00%
8.46

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

10 Years
5 Years
3 Years

6.02
-0.43
-5.07

EBITDA CAGR (%)

10 Years
5 Years
3 Years

9.02
19.60
4.52

PAT CAGR (%)

10 Years
5 Years
3 Years

29.05
80.96
119.66

P:E (Median)

8 Years
5 Years
3 Years

25.75
31.24
41.75

P:BV (Average)

8 Years
5 Years
3 Years

8.03
8.03
8.03

EV:EBITDA (Average)

8 Years
5 Years
3 Years

14.48
17.20
21.72

Quarterly Results

Standalone Figures in Rs. Crores

Description Mar 20 Mar 19 Var% Dec 19 Dec 18 Var% Sep 19 Sep 18 Var% Jun 19 Jun 18 Var%
Net Sales 228 231 -1% 237 204 16% 225 226 0% 234 220 6%
Expenses 169 181 -6% 188 189 -1% 175 168 4% 179 169 6%
EBITDA 59 50 17% 49 15 220% 50 58 -14% 55 51 7%
EBIDTM 26% 22% 21% 8% 22% 26% 23% 23%
Other Income 10 18 -42% 6 7 -15% 7 6 11% 17 6 203%
Interest 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 4 4 -2% 4 5 -8% 4 4 -6% 5 5 -8%
PBT 65 63 2% 51 18 184% 53 60 -12% 68 52 31%
Tax 18 23 -20% 13 4 185% 17 19 -11% 23 19 24%
PAT 46 41 14% 38 13 183% 36 41 -13% 44 33 34%
PATM 20% 18% 16% 7% 16% 18% 19% 15%
EPS 27.99 24.52 14% 23.02 8.12 183% 21.54 24.77 -13% 26.55 19.77 34%

Description Mar 20 Mar 19 Var% Dec 19 Dec 18 Var% Sep 19 Sep 18 Var% Jun 19 Jun 18 Var%
Net Sales 0 0 0 0 0 0 0 0 0 0 0 0
Expenses 0 0 0 0 0 0 0 0 0 0 0 0
EBITDA 0 0 0 0 0 0 0 0 0 0 0 0
EBIDTM 0% 0% 0% 0% 0% 0% 0% 0%
Other Income 0 0 0 0 0 0 0 0 0 0 0 0
Interest 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0
PBT 0 0 0 0 0 0 0 0 0 0 0 0
Tax 0 0 0 0 0 0 0 0 0 0 0 0
PAT 0 0 0 0 0 0 0 0 0 0 0 0
PATM 0% 0% 0% 0% 0% 0% 0% 0%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Description TTM Dec 18 Dec 17 Dec 16 Dec 15 Dec 14 Dec 13 Dec 12 Dec 11 Dec 10 Dec 09
Net Sales 924 849 698 993 940 867 798 687 590 509 473 Net Sales Growth 5% 22% -30% 6% 8% 9% 16% 17% 16% 8% Cost Of Goods Sold 300 269 237 412 437 405 367 301 247 170 167 Gross Profit 624 580 461 581 502 462 431 387 343 339 306 GP Margin 68% 68% 66% 59% 53% 53% 54% 56% 58% 67% 65% Total Expenditure 711 705 628 877 856 809 721 582 517 435 412 Power & Fuel Cost - 12 12 15 15 10 7 7 7 7 6 % Of Sales - 1% 2% 2% 2% 1% 1% 1% 1% 1% 1% Employee Cost - 131 110 154 123 114 101 84 80 63 52 % Of Sales - 15% 16% 16% 13% 13% 13% 12% 14% 12% 11% Manufacturing Exp. - 72 69 58 71 74 68 47 47 76 75 % Of Sales - 9% 10% 6% 8% 8% 8% 7% 8% 15% 16% General & Admin Exp. - 99 82 142 116 130 107 87 79 71 69 % Of Sales - 12% 12% 14% 12% 15% 13% 13% 13% 14% 15% Selling & Distn. Exp. - 116 91 81 85 70 65 50 51 46 40 % Of Sales - 14% 13% 8% 9% 8% 8% 7% 9% 9% 8% Miscellaneous Exp. - 5 27 15 9 6 5 6 6 3 40 % Of Sales - 1% 4% 2% 1% 1% 1% 1% 1% 1% 1% EBITDA 212 144 71 116 83 59 77 105 72 74 61 EBITDA Margin 23% 17% 10% 12% 9% 7% 10% 15% 12% 14% 13% Other Income 41 1,008 84 24 23 20 21 20 31 43 43 Interest 0 0 0 0 0 0 0 0 0 0 0 Depreciation 17 21 19 25 23 13 10 9 8 7 8 PBT 236 1,131 135 115 83 67 88 117 96 110 96 Tax 71 299 58 36 30 23 32 38 32 33 31 Tax Rate 30% 26% 38% 31% 36% 35% 37% 33% 33% 34% 32% PAT 165 839 94 79 54 43 56 78 64 63 65 PAT before Minority Interest 165 839 94 79 54 43 56 78 64 63 65 Minority Interest 0 0 0 0 0 0 0 0 0 0 0 PAT Margin 18% 99% 13% 8% 6% 5% 7% 11% 11% 12% 14% PAT Growth 28% 793% 19% 48% 24% -23% -29% 23% 1% -4% EPS 99.10 505.25 56.57 47.67 32.27 26.04 33.66 47.23 38.36 38.06 39.45

Description

TTM

Dec 18

Dec 17

Dec 16

Dec 15

Dec 14

Dec 13

Dec 12

Dec 11

Dec 10

Dec 09

Net Sales

924

849

698

993

940

867

798

687

590

509

473

Net Sales Growth

22%

-30%

16%

17%

16%

Cost Of Goods Sold

300

269

237

412

437

405

367

301

247

170

167

Gross Profit

624

580

461

581

502

462

431

387

343

339

306

GP Margin

68%

66%

59%

53%

54%

56%

58%

67%

65%

Total Expenditure

711

705

628

877

856

809

721

582

517

435

412

Power & Fuel Cost

% Of Sales

Employee Cost

131

110

154

123

114

101

% Of Sales

15%

16%

13%

12%

14%

12%

11%

Manufacturing Exp.

% Of Sales

10%

15%

16%

General & Admin Exp.

142

116

130

107

% Of Sales

12%

14%

12%

15%

13%

14%

15%

Selling & Distn. Exp.

116

% Of Sales

14%

13%

Miscellaneous Exp.

% Of Sales

EBITDA

212

144

116

105

EBITDA Margin

23%

17%

10%

12%

10%

15%

12%

14%

13%

Other Income

1,008

Interest

Depreciation

PBT

236

1,131

135

115

117

110

Tax

299

Tax Rate

30%

26%

38%

31%

36%

35%

37%

33%

34%

32%

PAT

165

839

PAT before Minority Interest

165

839

Minority Interest

PAT Margin

18%

99%

13%

11%

12%

14%

PAT Growth

28%

793%

19%

48%

24%

-23%

-29%

23%

-4%

EPS

99.10

505.25

56.57

47.67

32.27

26.04

33.66

47.23

38.36

38.06

39.45

Results Balance Sheet

Standalone Figures in Rs. Crores

Description Dec 18 Dec 17 Dec 16 Dec 15 Dec 14 Dec 13 Dec 12 Dec 11 Dec 10 Dec 09
Shareholder's Funds 1,540 733 664 592 554 523 484 410 346 467 Share Capital 17 17 17 17 17 17 17 17 17 17 Total Reserves 1,524 717 647 575 538 506 467 393 330 451 Non-Current Liabilities 492 430 399 395 390 13 338 13 -3 2 Secured Loans 0 0 0 0 0 0 0 0 0 0 Unsecured Loans 0 0 0 0 0 0 0 0 0 0 Long Term Provisions 507 455 413 396 392 12 337 12 0 0 Current Liabilities 551 352 300 539 260 112 195 481 84 99 Trade Payables 91 83 75 66 44 36 40 29 56 36 Other Current Liabilities 61 82 68 61 60 43 38 36 5 6 Short Term Borrowings 0 0 0 0 0 0 0 0 0 0 Short Term Provisions 399 187 157 412 156 32 117 416 23 56 Total Liabilities 2,583 1,516 1,363 1,525 1,204 648 1,016 904 427 568 Net Block 100 115 111 132 110 85 75 72 49 63 Gross Block 186 192 144 271 232 197 178 168 154 148 Accumulated Depreciation 61 51 25 140 122 112 103 96 90 85 Non Current Assets 693 637 613 579 581 171 460 120 51 64 Capital Work in Progress 17 9 30 7 28 9 2 0 2 1 Non Current Investment 4 0 0 0 0 0 0 0 0 0 Long Term Loans & Adv. 573 512 470 436 434 58 369 37 0 0 Other Non Current Assets 0 1 2 5 10 18 14 11 0 0 Current Assets 1,889 879 750 946 623 478 557 784 375 504 Current Investments 0 70 28 42 24 24 24 23 20 24 Inventories 113 158 164 167 177 152 131 113 61 58 Sundry Debtors 66 123 107 127 105 84 64 62 56 44 Cash & Bank 1,243 278 279 188 164 188 193 113 143 325 Other Current Assets 466 30 27 31 154 30 145 473 95 53 Short Term Loans & Adv. 436 221 145 390 137 9 128 456 89 43 Net Current Assets 1,338 527 450 407 363 366 361 303 292 405 Total Assets 2,583 1,516 1,363 1,525 1,204 648 1,016 904 427 568

Description

Dec 18

Dec 17

Dec 16

Dec 15

Dec 14

Dec 13

Dec 12

Dec 11

Dec 10

Dec 09

Shareholder's Funds

1,540

733

664

592

554

523

484

410

346

467

Share Capital

Total Reserves

1,524

717

647

575

538

506

467

393

330

451

Non-Current Liabilities

492

430

399

395

390

338

-3

Secured Loans

Unsecured Loans

Long Term Provisions

507

455

413

396

392

337

Current Liabilities

551

352

300

539

260

112

195

481

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

399

187

157

412

156

117

416

Total Liabilities

2,583

1,516

1,363

1,525

1,204

648

1,016

904

427

568

Net Block

100

115

111

132

110

Gross Block

186

192

144

271

232

197

178

168

154

148

Accumulated Depreciation

140

122

112

103

Non Current Assets

693

637

613

579

581

171

460

120

Capital Work in Progress

Non Current Investment

Long Term Loans & Adv.

573

512

470

436

434

369

Other Non Current Assets

Current Assets

1,889

879

750

946

623

478

557

784

375

504

Current Investments

Inventories

113

158

164

167

177

152

131

113

Sundry Debtors

123

107

127

105

Cash & Bank

1,243

278

279

188

164

188

193

113

143

325

Other Current Assets

466

154

145

473

Short Term Loans & Adv.

436

221

145

390

137

128

456

Net Current Assets

1,338

527

450

407

363

366

361

303

292

405

Total Assets

2,583

1,516

1,363

1,525

1,204

648

1,016

904

427

568

Cash Flow

Standalone Figures in Rs. Crores

Description Dec 18 Dec 17 Dec 16 Dec 15 Dec 14 Dec 13 Dec 12 Dec 11 Dec 10 Dec 09
Cash From Operating Activity -130 54 107 83 5 0 54 19 66 42 PBT 1,138 152 115 83 67 88 117 96 96 96 Adjustment -914 8 15 16 21 3 -8 -18 3 -19 Changes in Working Capital -50 -47 30 16 -49 -51 -15 -28 5 -5 Cash after chg. in Working capital 174 113 160 115 39 40 94 49 104 73 Interest Paid 0 0 0 0 0 0 0 0 0 0 Tax Paid -304 -60 -53 -32 -34 -40 -40 -30 -39 -32 Other Direct Exp. Paid 0 0 0 0 0 0 0 0 0 0 Extra & Other Items 0 0 0 0 0 0 0 0 1 1 Cash From Investing Activity 1,270 -48 -75 -68 11 7 -82 -9 176 2 Net Fixed Assets -3 -26 104 -19 -53 -26 -12 -13 -6 -7 Net Investments 66 -42 14 -18 0 -1 -1 -3 4 129 Others 1,206 21 -194 -30 63 34 -69 6 179 -120 Cash from Financing Activity -30 -22 -15 -12 -17 -5 0 0 -222 -45 Net Cash Inflow / Outflow 1,109 -16 17 4 -1 3 -28 10 20 -2 Opening Cash & Equivalents 10 26 9 5 7 4 31 22 1 3 Closing Cash & Equivalent 1,120 10 26 9 5 7 4 31 22 1

Description

Dec 18

Dec 17

Dec 16

Dec 15

Dec 14

Dec 13

Dec 12

Dec 11

Dec 10

Dec 09

Cash From Operating Activity

-130

107

PBT

1,138

152

115

117

Adjustment

-914

-8

-18

-19

Changes in Working Capital

-50

-47

-49

-51

-15

-28

-5

Cash after chg. in Working capital

174

113

160

115

104

Interest Paid

Tax Paid

-304

-60

-53

-32

-34

-40

-30

-39

-32

Other Direct Exp. Paid

Extra & Other Items

Cash From Investing Activity

1,270

-48

-75

-68

-82

-9

176

Net Fixed Assets

-3

-26

104

-19

-53

-26

-12

-13

-6

-7

Net Investments

-42

-18

-1

-3

129

Others

1,206

-194

-30

-69

179

-120

Cash from Financing Activity

-30

-22

-15

-12

-17

-5

-222

-45

Net Cash Inflow / Outflow

1,109

-16

-1

-28

-2

Opening Cash & Equivalents

Closing Cash & Equivalent

1,120

Financial Ratios

Standalone

Description Dec 18 Dec 17 Dec 16 Dec 15 Dec 14 Dec 13 Dec 12 Dec 11 Dec 10 Dec 09
Book Value (Rs.) 928 442 400 356 334 315 291 247 209 282 ROA 41% 7% 5% 4% 5% 7% 8% 10% 13% 12% ROE 74% 13% 13% 9% 8% 11% 18% 17% 16% 14% ROCE 100% 22% 18% 15% 12% 18% 26% 25% 24% 21% Fixed Asset Turnover 4.50 4.24 4.96 3.87 4.19 4.40 4.10 3.77 3.47 3.37 Receivable days 41 59 41 43 38 33 33 36 35 33 Inventory Days 58 83 59 64 67 62 63 52 42 49 Payable days 50 54 34 26 21 21 24 31 45 39 Cash Conversion Cycle 49 88 66 82 85 74 71 57 32 43 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Interest Cover 0 0 0 0 0 0 0 870 1,368 3,216

Description

Dec 18

Dec 17

Dec 16

Dec 15

Dec 14

Dec 13

Dec 12

Dec 11

Dec 10

Dec 09

Book Value (Rs.)

928

442

400

356

334

315

291

247

209

282

ROA

41%

10%

13%

12%

ROE

74%

13%

11%

18%

17%

16%

14%

ROCE

100%

22%

18%

15%

12%

18%

26%

25%

24%

21%

Fixed Asset Turnover

4.50

4.24

4.96

3.87

4.19

4.40

4.10

3.77

3.47

3.37

Receivable days

Inventory Days

Payable days

Cash Conversion Cycle

Total Debt/Equity

0.00

Interest Cover

870

1,368

3,216

Procter & Gamble Health Ltd.

Pharmaceuticals & Drugs - Domestic

BSE: 500126 | NSE: PGHL

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Annual Reports:

News Update

Procter & Gamble Health Ltd.

Pharmaceuticals & Drugs - Domestic

BSE: 500126 | NSE: PGHL

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Annual Reports:

News Update